NCT00023946: BMS-247550 in Treating Patients With Liver or Gallbladder Cancer |
|
|
| Terminated | 2 | 50 | US | ixabepilone, BMS-247550, epothilone B lactam, Ixempra, laboratory biomarker analysis | National Cancer Institute (NCI) | Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Localized Extrahepatic Bile Duct Cancer, Localized Gallbladder Cancer, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer | 07/05 | 11/09 | | |